OXiGENE (OXGN)
OXiGENE Market Cap: 13.06M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
OXGN Market Cap Rankings
| Overall | 3rd percentile | 4489 of 4664 |
| Sector | 5th percentile | 498 of 527 in Healthcare |
| Industry | 4th percentile | 157 of 164 in Biotechnology |
OXGN Market Cap Range, Past 5 Years
| Minimum | 12.25M | Mar 2011 |
| Maximum | 113.03M | Jun 2007 |
| Average | 45.92M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
You may also be interested in these OXGN related companies
OXGN News
OXiGENE Announces First Quarter 2012 Earnings Conference Call and Webcast
May 02, 4:00PM GlobeNewswire
May 02, 4:00PM GlobeNewswire
$OXGN forms bullish "Bottom Triangle" chart pattern. http://stks.co/3aqD
about 31 days ago by RecogniaEvents
about 31 days ago by RecogniaEvents
$OXGN forms bearish "Descending Continuation Triangle" chart pattern. http://stks.co/2rfT
about 78 days ago by RecogniaEvents
about 78 days ago by RecogniaEvents
$OXGN forms bearish "Continuation Diamond" chart pattern. http://stks.co/2o1z
about 80 days ago by RecogniaEvents
about 80 days ago by RecogniaEvents
$OXGN forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2o1x
about 80 days ago by RecogniaEvents
about 80 days ago by RecogniaEvents
$OXGN, lots of tweets, I am long at 1.24 ..nice vol, cancer and holding up well in this tape
about 86 days ago by 3DTradingtrader
about 86 days ago by 3DTradingtrader
$OXGN bought half position, stock acting VERY well in this tape, holding yesterdays gains on good volume.
about 86 days ago by shaneblackmon
about 86 days ago by shaneblackmon
$oxgn out 1.28 from 1.15 add yesterday... revisit if it takes out h.o.d.
about 114 days ago by kunal00
about 114 days ago by kunal00
Biotech Sector Shows No Signs of Slowing -- OXiGENE and Generex Poised for Growth
Feb 07, 8:20AM Marketwire
Feb 07, 8:20AM Marketwire
Small-Cap Stock Trade Review: OXiGENE Report Featured on MicroStockProfit.com
Dec 13, 6:50AM GlobeNewswire
Dec 13, 6:50AM GlobeNewswire
OXiGENE (OXGN), Azanta Danmark Enter ZYBRESTAT Partnership in Europe, Canada
Dec 12, 8:02AM Street Insider
Dec 12, 8:02AM Street Insider
OXiGENE Announces Purchase Agreement for Up to $20 Million With Lincoln Park Capital
Nov 28, 8:30AM GlobeNewswire
Nov 28, 8:30AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OXGN | 0.8601 | -0.04 | -4.43% | 13.66M |
| OXF | 7.68 | -0.01 | -0.13% | 80.05M |
| OWW | 3.65 | -0.10 | -2.67% | 389.21M |
| OLCB | 1.08 | +0.07 | +6.98% | 21.30M |
| OLBK | 10.54 | -0.01 | -0.14% | 71.74M |
| OKSB | 9.51 | +0.01 | +0.11% | 184.78M |
| OKS | 54.65 | -1.05 | -1.89% | 11.35B |
| OKE | 82.99 | -0.22 | -0.26% | 8.647B |
| SBR | 49.15 | -0.27 | -0.55% | 720.54M |
| SBNY | 61.44 | -0.52 | -0.84% | 2.861B |
